Eli Lilly and Co (NYSE:LLY)
| 323.05 Delayed Data As of 4:00pm ET |  +5.43 / +1.71%Today’s Change | 220.20 Today|||52-Week Range 330.85 | +16.95% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 317.62 |
| Today’s open | 319.37 |
| Day’s range | 317.68 - 324.56 |
| Volume | 2,562,100 |
| Average volume (3 months) | 3,061,177 |
| Market cap | $309.4B |
Data as of 4:00pm ET, 06/29/2022
Growth & Valuation
| Earnings growth (last year) | -9.81% |
| Earnings growth (this year) | +2.55% |
| Earnings growth (next 5 years) | +16.27% |
| Revenue growth (last year) | +15.40% |
| P/E ratio | 48.0 |
| Price/Sales | 8.89 |
| Price/Book | 34.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.28 | +0.55% |
| ABBVAbbVie | +1.51 | +0.99% |
| MRKMerck | +0.86 | +0.94% |
| AZNAstraZeneca | +0.96 | +1.46% |
Data as of 5:40pm ET, 06/29/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | $1.73 |
| Annual revenue (last year) | $28.3B |
| Annual profit (last year) | $5.6B |
| Net profit margin | 19.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
